CMMB
Morgan Stanley’s Chemomab Therapeutics CMMB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87M | Buy |
1,614,134
+1,496,974
| +1,278% | +$1.74M | ﹤0.01% | 4741 |
|
|
2025
Q1 | $128K | Buy |
117,160
+12,760
| +12% | +$13.9K | ﹤0.01% | 5909 |
|
|
2024
Q4 | $189K | Sell |
104,400
-297,872
| -74% | -$539K | ﹤0.01% | 5804 |
|
|
2024
Q3 | $632K | Buy |
402,272
+395,072
| +5,487% | +$620K | ﹤0.01% | 5292 |
|
|
2024
Q2 | $6.57K | Buy |
7,200
+4,403
| +157% | +$4.02K | ﹤0.01% | 6785 |
|
|
2024
Q1 | $2.18K | Sell |
2,797
-139,033
| -98% | -$108K | ﹤0.01% | 7052 |
|
|
2023
Q4 | $72.3K | Buy |
+141,830
| New | +$72.3K | ﹤0.01% | 6267 |
|
|
2023
Q3 | – | Sell |
-100
| Closed | -$132 | – | 7627 |
|
|
2023
Q2 | $132 | Sell |
100
-7,700
| -99% | -$10.2K | ﹤0.01% | 7481 |
|
|
2023
Q1 | $12.4K | Buy |
7,800
+1,200
| +18% | +$1.91K | ﹤0.01% | 6807 |
|
|
2022
Q4 | $21.1K | Buy |
6,600
+400
| +6% | +$1.28K | ﹤0.01% | 6677 |
|
|
2022
Q3 | $15K | Buy |
6,200
+605
| +11% | +$1.46K | ﹤0.01% | 6915 |
|
|
2022
Q2 | $21K | Buy |
+5,595
| New | +$21K | ﹤0.01% | 6952 |
|
|
2022
Q1 | – | Sell |
-11,643
| Closed | -$80K | – | 7980 |
|
|
2021
Q4 | $80K | Buy |
11,643
+11,548
| +12,156% | +$79.3K | ﹤0.01% | 6566 |
|
|
2021
Q3 | $1K | Sell |
95
-68
| -42% | -$716 | ﹤0.01% | 7760 |
|
|
2021
Q2 | $3K | Sell |
163
-171
| -51% | -$3.15K | ﹤0.01% | 7481 |
|
|
2021
Q1 | $10K | Sell |
334
-7,819
| -96% | -$234K | ﹤0.01% | 6931 |
|
|
2020
Q4 | $14K | Buy |
+8,153
| New | +$14K | ﹤0.01% | 6543 |
|
|
2019
Q4 | – | Sell |
-10,870
| Closed | -$25K | – | 6657 |
|
|
2019
Q3 | $25K | Buy |
+10,870
| New | +$25K | ﹤0.01% | 5942 |
|